FindTrial
Sign In

Clinical evaluation of the performance and safety on hollow fiber type dialyzer "APS-MA".

Clinical evaluation of the performance and safety on hollow fiber type dialyzer "APS-MA". - Clinical evaluation of APS-MA

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000027140
Enrollment
6
Registered
2017-04-28
Start date
2017-05-08
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Kidney Failure

Interventions

Hemodialysis using APS-MA and APS-MDNew for 2 weeks each

Sponsors

Rokko Island Konan Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1)Maintenance dialysis patients corresponding to - three times per week - more than three and a half hours in each dialysis session - hemodialysis for more than six months 2)Qb 200 mL/min is possible when the evaluation. 3)Outpatients. 4)Ability to give written informed consent. 5)Aged 20 to <80 years at the time of informed consent.

Exclusion criteria

Exclusion criteria: 1)Need to blood purification other than hemodialysis. 2)Judged ineligible by the attending physician.

Design outcomes

Primary

MeasureTime frame
1) Clearance 2) Reduction rate 3) Removal amount 4) Albumin leakage 5) Blood compatibility (Fluctuations in the number of white blood cells and platelets during hemodialysis) 6) Antithrombotic property—

Countries

Japan

Contacts

Public ContactHiroko Haibara

Rokko Island Konan Hospital Medical Engineering Center

ro_jinkoujinzoubu@kohnan.or.jp078-858-1111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026